137 related articles for article (PubMed ID: 32520413)
1. Acute myeloid leukemia with a severe coagulopathy and t(8;16)(p11;p13).
Hastings A; Apperley JF; Nadal-Melsio E; Brown L; Bain BJ
Am J Hematol; 2021 Jan; 96(1):163-164. PubMed ID: 32520413
[No Abstract] [Full Text] [Related]
2. Acute myeloid leukemia with t(8;16)(p11.2;p13.3)/KAT6A-CREBBP in adults.
Xie W; Hu S; Xu J; Chen Z; Medeiros LJ; Tang G
Ann Hematol; 2019 May; 98(5):1149-1157. PubMed ID: 30759270
[TBL] [Abstract][Full Text] [Related]
3. The clinical utility of genetic testing for t(8;16)(p11;p13) in congenital acute myeloid leukemia.
Daifu T; Kato I; Kozuki K; Umeda K; Hiramatsu H; Watanabe K; Kamiya I; Taki T; Nakahata T; Heike T; Adachi S
J Pediatr Hematol Oncol; 2014 Jul; 36(5):e325-7. PubMed ID: 24390445
[TBL] [Abstract][Full Text] [Related]
4. Translocation (12;15)(p13;q13) in a patient with relapsed acute myeloid leukemia.
Lim SW; Falk RE; Look RM; Fuerst MM; Lawrence GN; Kusuanco DA; Giles FJ
Cancer Genet Cytogenet; 1996 Feb; 86(2):165-7. PubMed ID: 8603347
[TBL] [Abstract][Full Text] [Related]
5. Do we still need morphologic evaluation in new era of advanced minimal residual disease analyses?
Yoon S; Kim H; Hur M; Han SH; Chung HJ; Moon HW; Yun YM; Lee MH
Int J Lab Hematol; 2019 Dec; 41(6):e145-e147. PubMed ID: 31050862
[No Abstract] [Full Text] [Related]
6. The EMA Review of Mylotarg (Gemtuzumab Ozogamicin) for the Treatment of Acute Myeloid Leukemia.
Ali S; Dunmore HM; Karres D; Hay JL; Salmonsson T; Gisselbrecht C; Sarac SB; Bjerrum OW; Hovgaard D; Barbachano Y; Nagercoil N; Pignatti F
Oncologist; 2019 May; 24(5):e171-e179. PubMed ID: 30898889
[TBL] [Abstract][Full Text] [Related]
7. Blood consult: acute myeloid leukemia and the t(8;21)(q22;22).
Park JH; Hedvat CV; Tallman MS
Blood; 2011 Mar; 117(10):2775-7. PubMed ID: 21285436
[No Abstract] [Full Text] [Related]
8. De novo acute myelogenous leukemia with trilineage myelodysplasia associated with t(8;21)(q22;q22).
Fujisawa S; Togawa J; Tanaka M; Koharazawa H; Aoba M; Fujita H; Murata T; Kanamori H; Matsuzaki M; Mohri H; Ishigatsubo Y
Intern Med; 1999 Jul; 38(7):607-11. PubMed ID: 10435370
[TBL] [Abstract][Full Text] [Related]
9. Prognosis of patients with t(8;16)(p11;p13) acute myeloid leukemia.
Brown T; Swansbury J; Taj MM
Leuk Lymphoma; 2012 Feb; 53(2):338-41. PubMed ID: 21846182
[No Abstract] [Full Text] [Related]
10. Spontaneous remission of congenital acute myeloid leukemia with t(8;16)(p11;13).
Wu X; Sulavik D; Roulston D; Lim MS
Pediatr Blood Cancer; 2011 Feb; 56(2):331-2. PubMed ID: 21157904
[No Abstract] [Full Text] [Related]
11. Gemtuzumab ozogamicin for
Lambert J; Pautas C; Terré C; Raffoux E; Turlure P; Caillot D; Legrand O; Thomas X; Gardin C; Gogat-Marchant K; Rubin SD; Benner RJ; Bousset P; Preudhomme C; Chevret S; Dombret H; Castaigne S
Haematologica; 2019 Jan; 104(1):113-119. PubMed ID: 30076173
[TBL] [Abstract][Full Text] [Related]
12. Unfavourable outcome of a patient with M2 acute non lymphocytic leukemia and a 47,XY,t(5;7)(q34;q21), +8 karyotype.
Testoni N; Zaccaria A; Celso B; Tura S
Haematologica; 1991; 76(1):65-8. PubMed ID: 2055562
[TBL] [Abstract][Full Text] [Related]
13. Marked hypereosinophilia and rash as initial presentation of acute myeloid leukemia with t(8;21).
Ong SY; Ho LP; Yeo PM; Ng HJ; Ang AL
Int J Hematol; 2017 Aug; 106(2):149-150. PubMed ID: 28390036
[No Abstract] [Full Text] [Related]
14. Translocation (2;4)(p23;q25): an additional case of a new recurrent anomaly in acute myeloid leukemia.
Shi G; Weh HJ; Hossfeld DK
Cancer Genet Cytogenet; 1993 Oct; 70(2):140-1. PubMed ID: 8242596
[TBL] [Abstract][Full Text] [Related]
15. Translocation t(8;16)(p11;p13) in acute nonlymphoblastic leukemia (M4) possibly secondary to Hodgkin's disease.
Barbata G; Carbone P; Mirto S; Santoro A; Giglio MC; Granata G
Cancer Genet Cytogenet; 1989 Jan; 37(1):127-31. PubMed ID: 2917327
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of adult patients treated for acute myeloid leukemia with inv 16 in Casablanca (Morocco).
Houssou B; Lamchahab M; Massi R; Oukkache B; Quessar A
Bull Cancer; 2018 Jun; 105(6):552-555. PubMed ID: 29735159
[No Abstract] [Full Text] [Related]
17. Marked bone marrow eosinophilia at the time of relapse of acute myeloblastic leukaemia in association with the appearance of translocation t(12;20)(q24;q11).
Partridge F; Richardson W; Kearns P; Wilcox R; Majumdar G
Leuk Lymphoma; 1996 Jun; 22(1-2):181-2. PubMed ID: 8724547
[TBL] [Abstract][Full Text] [Related]
18. Translocation (9;17) a novel translocation in acute myeloid leukaemia.
Brown SA; Czepulkowski B; Ireland R
Leuk Res; 1996; 20(11-12):987-8. PubMed ID: 9009258
[TBL] [Abstract][Full Text] [Related]
19. Concerns about how to use established minimal residual disease monitoring in the treatment of NPM1-mutant acute myeloid leukaemia (AML) following reduced intensity chemotherapy protocols for AML given as a result of the COVID-19 pandemic.
Farah N; Burt R; Ibrahim AR; Baker R; Kottaridis PD
Br J Haematol; 2020 Aug; 190(4):e208-e210. PubMed ID: 32609881
[No Abstract] [Full Text] [Related]
20. Acquired acute myelogenous leukemia after therapy for acute promyelocytic leukemia with t(15;17): a case report and review of the literature.
Betancourt-García RD; Castro J; Fernández AC; López-Enríquez A; Fradera J; Pacheco E
P R Health Sci J; 2009 Jun; 28(2):146-50. PubMed ID: 19530558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
